Organogenesis Holdings Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Organogenesis Holdings Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2016 to Q3 2024.
  • Organogenesis Holdings Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $12.3M, a 289% increase year-over-year.
  • Organogenesis Holdings Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$7.38M, a 157% decline year-over-year.
  • Organogenesis Holdings Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $4.95M, a 68.2% decline from 2022.
  • Organogenesis Holdings Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $15.5M, a 83.5% decline from 2021.
  • Organogenesis Holdings Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $94.2M, a 447% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$7.38M $12.3M +$9.16M +289% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$16.5M -$17M -$22.4M -421% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $5.81M -$2.1M +$869K +29.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $4.95M -$569K -$8.06M -108% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $13M $3.17M +$2.95M +1373% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $10M $5.32M -$3.43M -39.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $13.5M -$2.97M -$2.06M -225% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $15.5M $7.49M -$43.5M -85.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $59M $215K -$12.4M -98.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $71.4M $8.74M -$11.9M -57.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $83.3M -$913K -$10.9M -109% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $94.2M $51M +$33M +184% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $61.2M $12.6M -$8.18M -39.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $69.3M $20.7M +$25.9M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $43.5M $9.94M +$26.3M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $17.2M $18M +$20.6M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$3.38M $20.8M +$31.5M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$34.9M -$5.17M +$4.48M +46.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$39.4M -$16.3M -$647K -4.13% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$38.7M -$2.65M +$6.6M +71.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$45.3M -$10.7M +$2.34M +17.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$47.6M -$9.65M +$10.4M +51.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$58M -$15.7M +$6.82M +30.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$64.8M -$9.26M -$4.83M -109% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-18
Q3 2018 -$60M -$13.1M -$7.68M -142% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$52.3M -$20M -$20M -64648% Apr 1, 2018 Jun 30, 2018 10-K 2019-03-18
Q1 2018 -$32.3M -$22.5M -$24.8M -1088% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$7.53M -$4.43M -$4.25M -2385% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$3.28M -$5.4M -$5.39M Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 $2.11M $31K +$31.5K Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 $2.08M $2.28M +$2.29M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$209K -$178K Oct 1, 2016 Dec 31, 2016 10-K 2018-03-14
Q3 2016 -$14.5K* Jul 1, 2016 Sep 30, 2016 10-K 2018-03-14
Q2 2016 -$500* Apr 1, 2016 Jun 30, 2016 10-K 2018-03-14
Q1 2016 -$15.6K* Jan 1, 2016 Mar 31, 2016 10-K 2018-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.